JPMorgan raises Docusign stock price target to $80 on category leadership

Published 05/09/2025, 12:12
JPMorgan raises Docusign stock price target to $80 on category leadership

Investing.com - JPMorgan has raised its price target on Docusign Inc. (NASDAQ:DOCU) to $80.00 from $77.00 while maintaining a Neutral rating on the stock. According to InvestingPro data, DocuSign maintains impressive gross profit margins of 79.47% and trades at a P/E ratio of 13.95, suggesting strong operational efficiency.

The investment bank recognizes Docusign as a category-leading application software company that has redefined the contract-lifecycle management market with its primary eSignature-based offering, which commands over 60% market share.

Docusign has achieved significant market penetration, with adoption by more than 75% of Fortune 500 companies, largely driven by accelerated demand during the pandemic when businesses rapidly shifted to electronic signatures and contracts.

The company now faces challenges as pandemic-induced tailwinds fade, with JPMorgan noting that Docusign’s next growth phase depends on stronger up-selling to its large install base and broader adoption of its CLM and IAM product suite as it aims to reach $5B+ in revenue.

Despite Docusign being in the early stages of addressing its $50B+ total addressable market, JPMorgan indicates that near-term billings and revenue growth may remain uneven as the company works to establish a sustainable growth trajectory while managing leadership changes and sales organization restructuring.

In other recent news, DocuSign Inc . reported strong second-quarter results, surpassing earnings and revenue forecasts. The company posted earnings per share of $0.92, exceeding the expected $0.85, and achieved revenue of $800.6 million, beating the anticipated $779.78 million. Additionally, DocuSign’s net revenue retention rate improved to 102%, up from 101% in the previous quarter, indicating better customer retention. Analysts at RBC Capital raised their price target for DocuSign to $95 from $90, citing the company’s strong performance across various financial metrics. Evercore ISI also increased its price target to $92 from $90, noting the company’s 9% revenue growth, which outpaced expectations. BofA Securities raised its price target to $102 from $85, highlighting improved execution in DocuSign’s eSignature and Identity and Access Management (IAM) businesses. Needham maintained its Hold rating on the stock, acknowledging continued improvement under CEO Allan Thygesen’s leadership. These developments reflect a positive trajectory for DocuSign as it continues to enhance its market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.